Replies to post #76450 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

Still running with the Jensen angle is hysterical.

Yep. If a NAS small cap has a promising drug in phase 2, and needs funding, it's not unusual for a large cap to provide the funding. In exchange the small cap licenses their drug to the large cap in one or more markets (e.g. US, EU, Japan, China). But in the Microcrap scam world, PMCB is going to be bought up any day by Jensen. Without any clinical trials underway.

CIAB to actually get to a clinical trial so this gimmick technology

They apparently can't get the CIAB components GMP compliant, despite PRs from years ago, implying they were already there.

What Doctor would steer a patient to CIAB?

Yeah, that's the magic question. What Dr would steer a patient into what is essentially Metronomic chemo using a 30 yr old alkylating chemo drug. Where Metronomic chemo has poor responses against established tumors. As opposed to steering these late stage patients into targeted therapies in combination with other Chemo drugs, and radiation.

But look out world, here comes Kenny with his magic CIAB beads. Plop em next to a pancreatic tumor already stoma encapsulated so as to interfere with drug permeability, and presto the primary pancreatic tumor disappears. Kenny trying to convince his SHs the Ifosfamide is magically converted on the first pass, and super concentrates in the primary pancreatic tumor. Someone should ask him: Gee if it all gets slurped into the primary pancreatic tumor, what about the metastatic tumors on the liver, lung, brain, bone marrow, etc? Kenny can't have it both ways. How many years has Kenny been promising an IND? So much for magic beads.